332 related articles for article (PubMed ID: 23454976)
21. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
Choe JY; Park KY; Park SH; Lee SI; Kim SK
Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
[TBL] [Abstract][Full Text] [Related]
22. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
Giordanetto F; Kroemer RT
Protein Eng; 2003 Feb; 16(2):115-24. PubMed ID: 12676980
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
[TBL] [Abstract][Full Text] [Related]
24. New mimetic peptides of the kinase-inhibitory region (KIR) of SOCS1 through focused peptide libraries.
Doti N; Scognamiglio PL; Madonna S; Scarponi C; Ruvo M; Perretta G; Albanesi C; Marasco D
Biochem J; 2012 Apr; 443(1):231-40. PubMed ID: 22166051
[TBL] [Abstract][Full Text] [Related]
25. SOCS3 Silencing Promotes Activation of Vocal Fold Fibroblasts via JAK2/STAT3 Signaling Pathway.
Li X; Hu R; Wang H; Xu W
Inflammation; 2023 Aug; 46(4):1318-1331. PubMed ID: 37154979
[TBL] [Abstract][Full Text] [Related]
26. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
28. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
29. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
30. Understanding SOCS protein specificity.
Linossi EM; Calleja DJ; Nicholson SE
Growth Factors; 2018 Aug; 36(3-4):104-117. PubMed ID: 30318950
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
[TBL] [Abstract][Full Text] [Related]
32. SOCS3 and its role in associated diseases.
Yin Y; Liu W; Dai Y
Hum Immunol; 2015 Oct; 76(10):775-80. PubMed ID: 26429311
[TBL] [Abstract][Full Text] [Related]
33. LPS-induced SOCS3 antagonizes the JAK2-STAT5 pathway and inhibits β-casein synthesis in bovine mammary epithelial cells.
Geng Z; Shan X; Lian S; Wang J; Wu R
Life Sci; 2021 Aug; 278():119547. PubMed ID: 33930363
[TBL] [Abstract][Full Text] [Related]
34. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.
Hookham MB; Elliott J; Suessmuth Y; Staerk J; Ward AC; Vainchenker W; Percy MJ; McMullin MF; Constantinescu SN; Johnston JA
Blood; 2007 Jun; 109(11):4924-9. PubMed ID: 17317861
[TBL] [Abstract][Full Text] [Related]
35. Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses.
Hwang JY; Holland JE; Valenteros KB; Sun Y; Usherwood YK; Verissimo AF; McLellan JS; Grigoryan G; Usherwood EJ
Immunohorizons; 2019 Nov; 3(11):547-558. PubMed ID: 31748225
[TBL] [Abstract][Full Text] [Related]
36. Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.
Liau NP; Laktyushin A; Babon JJ
Methods Mol Biol; 2017; 1555():173-182. PubMed ID: 28092033
[TBL] [Abstract][Full Text] [Related]
37. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
38. Investigation of Novel Cavin-1/Suppressor of Cytokine Signaling 3 (SOCS3) Interactions by Coimmunoprecipitation, Peptide Pull-Down, and Peptide Array Overlay Approaches.
Williams JJL; Baillie GS; Palmer TM
Methods Mol Biol; 2020; 2169():105-118. PubMed ID: 32548823
[TBL] [Abstract][Full Text] [Related]
39. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
40. Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity.
Yan C; Cao J; Wu M; Zhang W; Jiang T; Yoshimura A; Gao H
J Biol Chem; 2010 Nov; 285(48):37227-39. PubMed ID: 20876575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
